Cogan John Francis 4
4 · GILEAD SCIENCES INC · Filed Apr 29, 2020
Insider Transaction Report
Form 4
Cogan John Francis
Director
Transactions
- Sale
Common Stock
2020-04-27$79.90/sh−2,413$192,799→ 54,860 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2020-04-27−2,413→ 2,416 totalExercise: $19.63Exp: 2020-05-11→ Common Stock (2,413 underlying) - Exercise/Conversion
Common Stock
2020-04-27$19.63/sh+2,413$47,367→ 57,273 total
Footnotes (2)
- [F1]The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- [F2]The options vested quarterly over the first year of service and were fully vested on May 11, 2011.